Tilvestamab Antibody
Tilvestamab (BGB149) is a humanized anti-AXL antibody with dual anti-tumor and anti-fibrotic properties. It functions by blocking Gas6-induced AXL activation, thereby inhibiting tumor progression, as demonstrated in studies using 786-0 renal cell carcinoma cells. This investigational antibody is a valuable tool for oncology and fibrosis research in both in vitro and in vivo models.
Product Specifications
Product Name Alternative
BGB 149, BGB149
Target
TAM Receptor
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
7.29 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
146.22 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2723-500 1x 500 µL
CD80 (B7-1) (C80/2723), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471867-500 1x 500 µL
CD8A (Cytotoxic-&Suppressor T-Cell Marker) (rC8/468), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 